Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Cited by (637)

Items 501–600 of 637

1. New Therapy Update Aprocitentan: An Endothelin Receptor Antagonist for the Treatment of Drug-Resistant Systemic Hypertension
   Michael Airo, William H. Frishman, Wilbert S. Aronow · 2023 · Cardiology in Review
2. Cost effectiveness of nonpharmacological prevention programs for diabetes: A systematic review of trial‐based studies
   Yongyi Xiong, Zhaohua Huo, Samuel Yeung Shan Wong, Benjamin Hon Kei Yip · 2023 · Chronic Diseases and Translational Medicine
3. Cost-utility and cost consequence of a telehealth intervention targeting improvement in addictive eating for Australian adults (the TRACE program)
   Janelle A. Skinner, Mark Leary, Olivia Wynne, Phillipa Hay, Clare Elizabeth Collins, Tracy L. Burrows · 2024 · Journal of Public Health
4. Impact of Alternative Medical Device Approval Processes on Costs and Health
   Benjamin P. George, Vinayak Venkataraman, Earl Ray Dorsey, S. Claiborne Johnston · 2014 · Clinical and Translational Science
5. The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need
   Pierre-Alexandre Dionne, Farzad Ali, Mendel P. Grobler · 2016 · Journal of health economics and outcomes research
6. ECONOMIC EVALUATION OF DIAGNOSTIC LOCALIZATION FOLLOWING BIOCHEMICAL PROSTATE CANCER RECURRENCE
   Daniel Ari Barocas, Mark Eliot Bensink, Kristin Berry, Zahra Musa, Carolyn Bodnar, Robert A. Dann, Scott David Ramsey · 2014 · International Journal of Technology Assessment in Health Care
7. Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable
   Sylvie Deuffic‐Burban, Yazdan Yazdanpanah · 2015 · Gut
8. Complex Ventral Hernia Repair Using Components Separation With or Without Biologic Mesh
   David Macarios, Michael Franz, Anne Marie Dawidczyk · 2014 · Annals of Plastic Surgery
9. Estimating economic efficiency of preclinical diagnostics of Parkinson's disease with cost-utility approach
   Irina A. Denisova, Tatiana V. Chubarova, Irina Bogatova, Sergey Vartanov, V. G. Kucheryanu, Victor M. Polterovich, Natalia A. Turdyeva, Шаклеина Марина Владиславовна · 2020 · Population and Economics
10. Navigated and Robotic-Assisted Pedicle Screw Placement Are More Cost-Effective Than Freehand Technique for Posterior Spinal Fusion in Idiopathic Scoliosis
    Amith Umesh, Patrick P. Nian, Sarah L. Lu, Ithika S. Senthilnathan, Troy B. Amen, Erikson T. Nichols, Ian Marsh, Emily R. Dodwell, Roger F. Widmann, Yongkang Zhang et al. · 2025 · Spine
11. Preterm birth attributable to exposure to chemicals used in plastic materials: a global estimate
    Sara Hyman, Jonathan M Acevedo, Leonardo Trasande · 2026 · EClinicalMedicine
12. Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method
    Qian Peng, Yue Yin, Min Liang, Mingye Zhao, Taihang Shao, Yaqian Tang, Zhiqing Mei, Hao Li, Wenxi Tang · 2023 · Cost Effectiveness and Resource Allocation
13. Survival Benefit and Cost Effectiveness of a Future Blood‐Based Diagnostic Test to Detect Cerebral Aneurysm Formation
    Aditya M. Mittal, Kamil W. Nowicki, Robert L. Dembinski, Ali A. Alattar, Michael Maurice McDowell, Michael P. Lang, Bradley A. Gross, Robert Max Friedlander · 2023 · Stroke Vascular and Interventional Neurology
14. Cost-effectiveness of hypothetical miRNA biomarker testing for post-treatment surveillance of HPV-negative OPSCC
    Rema Shah, Sidharth Tyagi, Dimitra P. Vageli, Benjamin L. Judson · 2023 · Oral Oncology Reports
15. Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review
    Claire de Oliveira, Joyce Mason, Bahar Amani, Terri Rodak, Péter Szatmári, Joanna L. Henderson, Darren Courtney · 2025 · Value in Health
16. Do we need cost-effectiveness analysis of brachytherapy for cervical cancer in the 3D image-guided era?
    Érica Aranha Suzumura, Layse Martins Gama, de Carvalho HA, Patrícia Coelho de Soárez · 2020 · Cancer Reports and Reviews
17. Is herpes zoster vaccination likely to be cost-effective in Canada?
    Alexander D. Peden, Stephenson B. Strobel, Evelyn L. Forget · 2014 · Canadian Journal of Public Health
18. The Clinical and Ethical Practice of Neuromodulation – Deep Brain Stimulation and Beyond
    Markus Christen, Sabine Müller · 2018 · Frontiers research topics
19. International experience in determining the cost-effectiveness thresholds
    Tatiana Pavlovna Bezdenezhnykh, Nuriya Zagitovna Musina, V. K. Fedyaeva, Т. S. Teptsova, Лемешко Валерия Александровна, V. V. Omelyanovsky · 2019 · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
20. COST-EFFECTIVENESS ANALYSIS OF PROLANIS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THREE COMMUNITY HEALTH CENTERS IN BANDUNG, INDONESIA
    Riani Tanjung, Yulia Wardati, Nyi Mekar Saptarini · 2021 · International Journal of Applied Pharmaceutics
21. CT Colonography Versus Optical Colonoscopy: Cost-Effectiveness in Colorectal Cancer Screening
    Orysya Svystun, Marilyn Zeman, Michael Seidler, Christopher I. Fung · 2022 · EMJ Innovation
22. Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
    G. Fekadu, Jiaqi Yao, J. You · 2022 · Scientific Reports
23. [Evaluation of the anal position in newborns and children with chronic constipation. Incidence of anterior ectopic anus].
    R. Núñez-Ramos, M González-Velasco, R. Núñez Núñez, EM Enríquez Zarabozo, I Vargas Muñoz, E Blesa Sánchez · 2011 · PubMed
24. Direkte Kosten sozialer Angststörung bei Jugendlichen und Kosteneffektivität der Psychotherapie
    Judith Dams, K. Kronmüller, E. Leibing, R. Steil, P. Henningsen, F. Leichsenring, H. Peseschkian, R. Rosner, Simone Salzer, Annette Stefini et al. · 2018 · Psychiatrische Praxis
25. An Overview of Health Economic Aspects of Perinatal Depression
    Stavros Petrou, C Jane Morrell, Martin Richard John Knapp · 2015 · Wiley eBooks
26. Economic evaluation of a mobile phone text-message intervention for Australian adults with type 2 diabetes
    Karen Waller, Anagha Killedar, Susan E Furber, Eng Joo Tan, Alice A. Gibson, Adrian Ernest Bauman, Alison Hayes · 2023 · mHealth
27. Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada
    Yeva Sahakyan, Ayşegül Erman, William W. L. Wong, Christina A. Greenaway, Naveed Zafar Janjua, Jeffrey C. Kwong, Beate Sander · 2024 · Viruses
28. The Cost-Effectiveness of Continuous Pressure Measurement in the Diagnosis of Acute Compartment Syndrome
    Yasser C Bouklouch, Milan Sen · 2025 · Journal of Bone and Joint Surgery
29. Community-involved economic evaluation and development of a cost-effectiveness calculator for two peer-driven substance use interventions
    Sierra Castedo de Martell, Margaret B. Moore, Hannah Wang, Lori Holleran Steiker, Johnny Michael Wilkerson, Sheryl McCurdy, Nalini Ranjit, H. Shelton Brown · 2025 · Frontiers in Public Health
30. The value of extending healthy life expectancy: A framework for healthcare policy evaluation
    Kazuya Ito, Yusuke Tanizawa, Ryuta Takashima · 2025 · Economics & Human Biology
31. Points to consider for incorporating climate impacts into health economic evaluation
    Jule Oldenburg, Oliver Lange, Mattis Keil, Scott McAlister, Rachael Lisa Morton, Don Husereau, Wolf H. Rogowski · 2026 · The European Journal of Health Economics
32. Population-level assessment of healthcare cost-effectiveness from the payer’s perspective in the Czech Republic: methodology and threshold setting using administrative data
    Martina Fojtíková, Jindřich Fiala · 2026 · Journal of Medical Economics
33. Irrelevance of explicit cost–effectiveness thresholds when coverage decisions can be reversed
    Anirban Basu · 2013 · Expert Review of Pharmacoeconomics & Outcomes Research
34. Towards an expanded definition of value
    Matthew Smith, Christopher J. Standaert · 2013 · The Spine Journal
35. A conceptual framework (Cat-4) for estimating clinical relevance of evidence related to oral diagnosis
    Rahul Nair, Amanda-MaeNguee Ai-Min · 2015 · Journal of Interdisciplinary Dentistry
36. 항암제 경제성평가에서 점증적 비용-효과비와 의사결정
    Hoe Sang Kim, 고수경, 강혜영, Young-Ju Kang · 2014 · The Journal of Health Technology Assessment
37. Managing a bone marrow transplant centre to maximise patients' health benefits
    Bo Li, Antonio Arreola‐Risa · 2022 · International Journal of Production Research
38. Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan
    Yu Kondo, Tomoya Tachi, Takayoshi Sakakibara, Jun Kato, Aki Kato, Takahito Mizuno, Yoshio Miyake, Hitomi Teramachi · 2022 · Supportive Care in Cancer
39. Measuring the Value of Prescription Drugs
    Neumann Peter J., Cohen Joshua T., Ollendorf Daniel A · 2021 · Oxford University Press eBooks
40. The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach
    Stefano Capri, Fernando Antoñanzas, Rosella Levaggi · 2023 · Expert Review of Pharmacoeconomics & Outcomes Research
41. Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate Cancer
    Roberto Ravasio · 2016 · Global & Regional Health Technology Assessment
42. Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
    Satar Rezaei, Maryam Bavandpour, Mohammadreza Mobinizadeh, Rajabali Daroudi · 2024 · BMC Research Notes
43. Critical Appraisal of Costly Therapy Modalities for Heart Failure in a Developing Country
    Diego Chemello, Lívia Adams Goldraich, Juglans Alvarez, Luís Beck da Silva Neto, Nadine Clausell · 2013 · Current Heart Failure Reports
44. Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer
    Yugo Chisaki, Nobuhiko Nakamura, Yoshitaka Yano · 2016 · Biological and Pharmaceutical Bulletin
45. Decision Rules in Cost-Utility Analysis of Health Technologies
    Udomsak Saengow · 2021 · Walailak Journal of Science and Technology (WJST)
46. Neonatal Screening for Critical Congenital Heart Defects
    Andrew K Ewer · 2019 · MDPI eBooks
47. Understanding the Cost-Effectiveness of Hearing Aids and Surgery for the Treatment of Otosclerosis
    Danielle M. Gillard, Jeffrey D. Sharon · 2022 · Current Otorhinolaryngology Reports
48. Prostate Artery Embolization Versus Transurethral Resection of the Prostate: Is Cost-Effectiveness Analyses Useful to Improve Access to Image-Guided Procedures in the United States?
    Julie C. Bulman, Ammar Sarwar · 2022 · Journal of the American College of Radiology
49. The Rationale for Economic Evaluation in Speech and Language: Cost, Effectiveness, and Cost-effectiveness
    Jeffrey S. Hoch, Bridgette P. Smith, Jiyeong Y Kim, Carolyn S. Dewa · 2022 · Seminars in Speech and Language
50. COST-EFFECTIVENESS ANALYSIS OF GASTRITIS THERAPY IN AN AIR FORCE HOSPITAL IN BANDUNG, INDONESIA
    Riani Tanjung, Yulia Wardati, DINI NUR AZIZAH, Bhekti Pratiwi, Resmi Mustarichie, Nyi Mekar Saptarini · 2022 · International Journal of Applied Pharmaceutics
51. Cost-Effectiveness: A Key Step in Technology Transfer
    Steven David Pinkerton, David R. Holtgräve · 2010 · Springer eBooks
52. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis
    Joshua A. Barocas, Benjamin Paul Linas · 2016 · Clinical Infectious Diseases
53. Health technology assessments alongside the translational pathway of innovations in oncology
    Melanie A. Lindenberg · 2020
54. The epidemiological and economic impact of a cell-based quadrivalent influenza vaccine in an adult population in the US: a dynamic modeling approach
    Van Hung Nguyen, Yvonne Hilsky, Joaquín Federico Mould-Quevedo · 2020 · Research Square
55. Análisis e interpretación de los resultad os de las evaluaciones económicas. Reglas de decisión
    Javier Soto Álvarez · 2012
56. The quality of life and cost-effectiveness of treatment after a serious neurosurgical illness
    Kirsi Malmivaara · 2014 · Työväentutkimus Vuosikirja
57. Implementing combined decision models in healthcare settings: the Simon and Pauker- Kassirer models
    Ofir Ben‐Assuli · 2013 · Journal of Hospital Administration
58. The Overuse of Intensity-modulated Radiotherapy and the Role of the Healthcare Payer
    D. Andrew Loblaw · 2012 · Clinical Oncology
59. Botox for the Neurogenic Bladder
    Catherine J. Harris, Roger Roman Dmochowski, William M. Reynolds · 2013 · Current Bladder Dysfunction Reports
60. Assessing Prevention for Positives: Cost-Utility Assessment of Behavioral Interventions for Reducing HIV Transmission
    Sada Soorapanth, Stephen E. Chick · 2013 · International series in management science/operations research/International series in operations research & management science
61. Associations Between Funding Source and Results of Cost Effectiveness Analyses of Drugs Used in Breast Cancer
    Jordan D. Lane · 2015 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
62. Searching for the social value of a QALY in the Netherlands: The Willingness to Pay for a QALY
    Marko O. Obradović · 2012
63. Cost-Effectiveness Analysis of Long-Acting Bronchodilators for the Treatment of COPD (Moderate to Very Severe)
    Roberto Ravasio · 2015 · Global & Regional Health Technology Assessment
64. Assessing the Impact of Integrated Personal Health and Care Services: The Need for Modelling
    Cristiano Codagnone, Maghiros Ioannis, David Broster, Lupiañez Villanueva Francisco, Lluch Maria · 2011 · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
65. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting Collecting economic data at the same time as evidence of effectiveness maximises the information available for analysis but requires proper consideration at the design stage
    Stavros Petrou, Alastair McIntosh Gray · 2011
66. Pharmacoeconomic methods for estimating cost-effectiveness and budget impact of cancer treatments in Finland
    Timo T. Purmonen · 2012 · UEF eRepo (University of Eastern Finland)
67. HIV und HCV unter ökonomischer Lupe
    Eva Wolf, Robin Rüsenberg · 2015 · MMW - Fortschritte der Medizin
68. Management of incidentally detected Barrett's esophagus in young patients: extending the guidelines with a Markov process cost-utility analysis
    Charles R. Boardman · 2015
69. Health Coaching for Chronic Disease Management: A Program Evaluation Conducted at Denver Health Managed Care
    Adam Altschuh · 2015
70. Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists C. Camps-HerreroL. Paz-AresM. CodesR. Lopez-Lopez • A. Anton-TorresP. Gascon-VilaplanaV. Guillem-Porta • A. CarratoJ. J. Cruz-HernandezC. Caballero-Dõ´az • A. Blasco-CordellatJ. A. Moreno-NogueiraE. Dõ´az-Rubio
    Luis G Paz-Ares, Alessandro Carrato · 2014
71. Cost-Effectiveness Analysis and the Value for Money of Health Technologies
    Steven Simoens · 2012 · Advances in bioinformatics and biomedical engineering book series
72. Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate Cancer
    Roberto Ravasio · 2016 · Global & Regional Health Technology Assessment
73. Training obstetrics nurses and behavioral health care providers in behavioral activation for antenatal depression
    Samuel H. Hubley · 2013 · CU Scholar (University of Colorado Boulder)
74. Genomic Medicine in Developing Countries and Resource-Limited Environments
    Θεοδώρα Κάτσιλα, Konstantinos A. Mitropoulos, Zahurin Mohamed, Diego A. Forero, Paul Laissue, Ambroise Wonkam, Catalina López-Correa, Wasun Chantratita, A. López LLerena, Bassam R. Ali et al. · 2016 · Elsevier eBooks
75. Análisis e interpret Ación De los result ADos De l As ev Alu Aciones económic As. r egl As De Decisión
    Capítulo Xi · 2012
76. Health Economic Issues Related to Adult Lumbar Scoliosis
    Corneliu Bolbocean, Chessie Robinson, Neil S. Fleming, Richard A. Hostin · 2017 · Springer eBooks
77. The Cost Effectiveness of Screening for Early Stage Lung Cancer and the Testing and Treatment of Molecular Subgroups Among Non-small Cell Lung Cancer Patients in the Province of Ontario, Canada
    Mallory Thao · 2014 · TSpace (University of Toronto)
78. Application of Decision Analytic Model in Health Economic Evaluation: Smoking Cessation Cases
    Septiara Putri · 2016 · Jurnal Ekonomi Kesehatan Indonesia
79. Theories of Health Care Cost-Effectiveness Analysis
    Richard L. Ernst · 2017 · SocArXiv (OSF Preprints)
80. How Economic Findings Can Inform Prevention Research in Cardiovascular Disease
    Scott Dennis Grosse · 2017 · American Journal of Preventive Medicine
81. Reply to the Letter to the Editor regarding “The 5-year cost-effectiveness of anterior cervical discectomy and fusion or cervical disc replacement: a Markov analysis”
    Steven J. McAnany, Sheeraz A. Qureshi · 2018 · The Spine Journal
82. Cost-Effectiveness of Anti-TNF Therapy for the Management of Inflammatory Bowel Disease
    Candace L. Beilman · 2016 · ERA: Education and Research Archive (University of Alberta)
83. The Cost-Effectiveness of Various Surgical Procedures in the Cervical Spine
    Blake N. Staub, Todd James Albert · 2018 · Springer eBooks
84. Comprehensive Investigation of Radiation Techniques for Whole Breast and Post-Mastectomy Irradiations
    Yibo Xie · 2020
85. Critical Care Is a Bargain? An Intensive Look at Value for Money in the ICU*
    Alain Beaudry · 2020 · Critical Care Medicine
86. Cost-Effectiveness of Early Oral Feeding Following Total Gastrectomy
    Akinori Hisashige, Nobuyuki Shimizu, Yasuyuki Seto · 2020 · Global Journal of Health Science
87. Evolution, Current Concepts, and Future Developments in Arthroscopic Surgery of the Hip
    Ori Weiss, Andrew Kean Seng Lim, Jessica Kamal, Vikas Khanduja · 2021 · Springer eBooks
88. Cost-Effectiveness Analysis of Long-Acting Bronchodilators for the Treatment of COPD (Moderate to Very Severe)
    Roberto Ravasio · 2015 · Global & Regional Health Technology Assessment
89. Optimizing Surveillance in Barrett’s Esophagus: From Chemoprevention and Biomarkers to Cost-effectiveness and Survival
    Florine Kastelein · 2014 · EUR Research Repository (Erasmus University Rotterdam)
90. Invited Commentary
    David Linshaw, Jennifer S. Gass · 2021 · Journal of the American College of Surgeons
91. The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in an Adult Population in the US: A Dynamic Modeling Approach
    Van Hung Nguyen, Yvonne Hilsky, Joaquín Federico Mould-Quevedo · 2020 · Research Square
92. Pharmacoeconomics
    Joseph F. Dasta, Sandra L. Kane‐Gill · 2011 · Elsevier eBooks
93. 6 Value-based care Aging spine value-based care for Value-Based Care in the Aging Spine
    2020 · Thieme eBooks
94. Cost-Effective Treatment of Clostridiodes difficile Infection
    Joan L. Robinson · 2022 · Clinical Infectious Diseases
95. Impact of Operational Constraints on the Implied Value of Life
    Onur Öztürk, Mehmet A. Begen, Gregory S. Zaric · 2022 · Lecture notes in management and industrial engineering
96. Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market Design
    Louis P. Garrison · 2022 · Value in Health
97. Inequality in Drug Utilization among Chronic Myeloid Leukaemia Patients in Malaysia: A Cost-Utility Analysis
    Sharifa Ezat Wan Puteh, Ellyana Mohamad Selamat, Azimatun Noor Aizuddin, Nor Rafeah Tumian, Jameela Sathar · 2022 · Asian Pacific Journal of Cancer Prevention
98. Survival Benefit and Cost-Effectiveness Analysis of a Future Blood-Based Diagnostic Test to Detect Cerebral Aneurysm Formation: A hypothetical modeling study
    Aditya M. Mittal, Kamil W. Nowicki, Robert L. Dembinski, Ali A. Alattar, Michael Maurice McDowell, Michael J. Lang, Bradley A. Gross, Robert Max Friedlander · 2023 · Research Square
99. Entwicklung, aktuelle Konzepte und zukünftige Entwicklungen in der arthroskopischen Hüftchirurgie
    Ori Weiss, Andrew Lim, Jessica Kamal, Vikas Khanduja · 2023 · Springer eBooks
100. The Impact of Surgical Expertise on the Cost-Effectiveness of Stapes Surgery
     Mauricio Cohen‐Vaizer, Michael Dreyfuss, Shoorok Na'ara, Shadi Shinnawi, Roman D. Laske · 2023 · Audiology and Neurotology